A nine country study of the burden of non‐severe nocturnal hypoglycaemic events on diabetes management and daily function
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Aims: The purpose of this study was to explore the burden and impact of non‐severe nocturnal hypoglycaemic events ( NSNHEs ) on diabetes management, patient functioning and well‐being in order to better understand the role that NSNHEs play in caring for persons with diabetes and facilitate optimal diabetes treatment management strategies. Methods: A 20‐min survey assessing the impact of NSNHEs was administered to patients with self‐reported diabetes age 18 or older via the Internet in nine countries ( USA , UK , Germany, Canada, France, Italy, Spain, The Netherlands and Sweden) who experienced an NSNHE in the last month. Questions captured reasons for and length of the event, and impacts on diabetes management, daily function, sleep and well‐being. Results: A total of 20 212 persons with Type 1 diabetes mellitus ( T1DM ) and Type 2 diabetes mellitus ( T2DM ) were screened of which 2108 respondents were eligible. Respondents initiated, on average, an additional 3.6 glucose monitoring tests, and did not resume usual functioning for an average of 3.4 hours after the NSNHE . Of the respondents using insulin, 15.8% decreased their insulin dose over an average of 3.6 days. NSNHEs also impacted sleep, with 10.4% not returning to sleep that night. Next day functioning was affected with 60.3% (n = 1273) feeling the need to take a nap and/or rest (with 65.5% of those actually taking a nap/rest) and 40.2% (n = 848) wanting to go to bed earlier than usual. A total of 21.4% were restricted in their driving the next day. These events also resulted in decreased well‐being with 39.6% of respondents feeling ‘emotional low’ the following day. Conclusions: NSNHEs have serious consequences for patients. Greater attention to patient and physician education regarding the burden of NSNHEs and incorporation of corrective actions in treatment plans is needed to facilitate patients reaching optimal glycaemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Prospective Study of Sleep Duration and Coronary Heart Disease in Women
Ayas, N. T., White, D. P., Manson, J. E., Stampfer, M. J., Speizer, F. E., Malhotra, A., & Hu, F. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.2.205 · Cited by 1,155 · cited 1×
“Sleep is considered to be a necessary prerequisite to optimal functioning and sleep deprivation can lead to increased body mass index and obesity [15], greater prevalence of diabetes or impaired glucose tolerance [16], higher blood pressure or higher prevalence of hypertension [17,18] or cardiovascular disease [19,20].”
BackgroundLong-term effects of intensive glucose lowering on cardiovascular outcomes
The ACCORD Study Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006524 · Cited by 1,035
Association of usual sleep duration with hypertension: the Sleep Heart Health Study
Gottlieb, D. J., Redline, S., Nieto, F. J., Baldwin, C. M., Newman, A. B., Resnick, H. E., & Punjabi, N. M. (2006) · Sleep · doi:10.1093/sleep/29.8.1009 · Cited by 947 · cited 1×
“Sleep is considered to be a necessary prerequisite to optimal functioning and sleep deprivation can lead to increased body mass index and obesity [15], greater prevalence of diabetes or impaired glucose tolerance [16], higher blood pressure or higher prevalence of hypertension [17,18] or cardiovascular disease [19,20].”
BackgroundHypoglycemia in patients with type 2 diabetes mellitus
Miller, C. D., Phillips, L. S., Ziemer, D. C., Gallina, D. L., Cook, C. B., & El-Kebbi, I. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1653 · Cited by 341
The impact of non-severe hypoglycemic events on work productivity and diabetes management
Brod, M., Christensen, T., Thomsen, T. L., & Bushnell, D. M. (2011) · Value in Health · doi:10.1016/j.jval.2011.02.001 · Cited by 284
Self-citationBrod, M., Pohlman, B., Wolden, M., & Christensen, T. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0234-3 · Cited by 71
Self-citationKawabe, H., & Saito, I. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802064575 · Cited by 16 · cited 1×
“Sleep is considered to be a necessary prerequisite to optimal functioning and sleep deprivation can lead to increased body mass index and obesity [15], greater prevalence of diabetes or impaired glucose tolerance [16], higher blood pressure or higher prevalence of hypertension [17,18] or cardiovascular disease [19,20].”
Background
Cited by
Short- and long-term health consequences of sleep disruption
Medic, G., Wille, M., & Hemels, M. (2017) · Nature and Science of Sleep · doi:10.2147/nss.s134864 · Cited by 1,776
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Coming of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters-Weijnen, C., Forsén, T., Galstyan, G., Geelhoed-Duijvestijn, P., Goldfracht, M., Gydesen, H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.004 · Cited by 71
“The changes in patient behaviour in response to hypoglycaemia reported here have been previously observed in response to both nocturnal [6] and overall non-severe hypoglycaemia [7,13,27].”
BackgroundResultPedersen‐Bjergaard, U., Agesen, R. M., Brøsen, J. M. B., Alibegovic, A. C., Andersen, H. U., Beck‐Nielsen, H., Gustenhoff, P., Hansen, T. K., Hedetoft, C., Jensen, T. J., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14574 · Cited by 16
Metadata
- Authors
- Brod, M., Wolden, M., Christensen, T., & Bushnell, D. M.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2013-02-25
- Volume
- 15
- Issue
- 6
- Pages
- 546-557
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2059631102
- Cited by
- 73
- References
- 7
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.